Regístrese
¿Aún no está registrado?
Información relevante

Consulte los artículos y contenidos publicados en este medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Trichomonas vaginalis: tratamiento y resistencia a nitroimidazoles
Información de la revista
Vol. 19. Núm. 3.Marzo 2001
Páginas 91-144
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. 3.Marzo 2001
Páginas 91-144
DOI: 10.1016/S0213-005X(01)72580-3
Acceso a texto completo
Trichomonas vaginalis: tratamiento y resistencia a nitroimidazoles
Visitas
95168
Fernando Vázqueza,1
Autor para correspondencia
fvazquez@correo.uniovi.es
fvazquez@hmm.es

Correspondencia: Dr. F. Vázquez Valdés. Departamento de Biología Funcional. Área de Microbiología. Facultad de Medicina. Universidad de Oviedo. C./ Julián Clavería s/n. 33006 Oviedo.
, Ma José Garcíab, Francisco Pérezb, Virgilio Palacioc
a Departamento de Biología Funcional. Área de Microbiología. Facultad de Medicina de Oviedo y Servicio de Microbiología. Hospital Monte Naranco
b Servicio de Microbiología. Hospital Central de Asturias
c Servicio de Dermatología y Enfermedades de Transmisión Sexual. Hospital Monte Naranco. Oviedo
Este artículo ha recibido
95168
Visitas
Información del artículo
El Texto completo solo está disponible en PDF
Bibliografía
[1.]
R.E. Trussell
Trichomonas vaginalis and trichomoniasis
Charles C. Thomas, (1947)
[2.]
K. Maeda,T. Osata,H. Umeza
A new antibiotic, azomycin
J Antibiot, 6 (1953), pp. 182
[3.]
C.D. Freeman,N.E. Klutman,K.C. Lamp
Metronidazole. A therapeutic review and update
Drugs, 54 (1997), pp. 679-708
[4.]
C. Cosar,L. Julou
Activité de l’(hydroxy-2-éthyl)-1-méthyl-2-nitro-5-imidazole (8823 R.P.) vis-à-vis des infections expérimentales à trichomonas vaginalis
Ann Inst Pasteur, 96 (1959), pp. 238-241
[5.]
P. Durel,V. Roiron,H. Siboulet,L.J. Borel
Trial of an antitrichomonal derivate of imidazole (8823 R.P.) Comptes Rendus Soc Franç Gynécol, 29 (1959), pp. 36
[6.]
P. Durel,V. Roiron,A. Siboulet,L.J. Borel
Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 R. P
Br J Vener Dis, 36 (1960), pp. 21-26
[7.]
D.I. Edwards
Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action
J. Antimicrob Chemother, 31 (1993), pp. 9-20
[8.]
H.L. Howes,J.E. Lynch,J.L. Kiulin
Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa
Antimicrob Agents Chemother, 9 (1969), pp. 261-266
[9.]
J. Wallin,A. Forsgren
Tinidazole – a new preparation for Trichomonas vaginalis infections. II. Clinical evaluation of treatment with a single oral dose
Br J Vener Dis, 50 (1974), pp. 148-150
[10.]
L. Hillström,L. Petterson,E. Pálsson
Comparison of ornidazole and tinidazole in single- dose treatment of trichomoniasis in women
Br J Vener Dis, 53 (1977), pp. 193-194
[11.]
R. Jones,P. Enders
An evaluation of tinidazole as single- dose therapy for the treatment of Trichomonas vaginalis
Med J Aust, 2 (1977), pp. 679-680
[12.]
N. Kawamura
Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in man
Br J Vener Dis, 54 (1978), pp. 81-83
[13.]
M.W. Miller,H.L. Howes,A.R. English
Tinidazole, a potent new antiprotozoal agent
Antimicrob Agents Chemother, 169 (1970), pp. 257-260
[14.]
F. Vázquez Valdés
Tricomoniasis (Ponencia)
pp. 27-29
[15.]
D.H.H. Robertson,R. Heyworth,C. Harrison,W.R.H. Lumsden
Treatment failure in Trichomonas vaginalis infections in females. I. Concentrations of metronidazole in plasma and vaginal content during normal and high dosage
J Antimicrob Chemother, 21 (1988), pp. 373-378
[16.]
M. Sköld,H. Gnarpe,L. Hillström
Ornidazole: A new antiprotozoal compound for treatment of Trichomonas vaginalis infections
Br J Vener Dis, 53 (1977), pp. 44-48
[17.]
J. Symonds
Secnidazole- a nitroimidazole with a prolonged serum halflife
J Antimicrob Chemother, 5 (1979), pp. 484-486
[18.]
A/ Notowicz,E. Stolz,G.A.J. de Koning
First experiences with single- dose treatment of vaginal trichomoniasis with carnidazole (R25831)
Br J Vener Dis, 53 (1977), pp. 129-131
[19.]
A. Cantone,I. de Carneri,A. Emanueli,P.N. Giraldi,W. Logemann,R. Longo,G. Meinardi,G. Monti,G. Nannini,G. Tosolini,G. Vita
Nitroimidazole: A new systemic trichomonacide
G Mal Infett Parassit, 21 (1969), pp. 954-958
[20.]
R.R. Willcox
How suitable are available pharmaceuticals for the treatment of sexually transmited diseases? 1. Conditions presenting as genital discharges
Br J Vener Dis, 53 (1977), pp. 314-323
[21.]
J.A. Uprcroft,R.A. Campbell,K. Benakli,P. Upcroft,P. Vanelle
Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and–resistant Giardia, Trichomonas, and Entamoeba spp
Antimicrob Agents Chemother, 43 (1999), pp. 73-76
[22.]
D.M. Brown,J.A. Upcroft,P. Upcroft
An alternative keto acid oxidoreductase in Trichomonas vaginalis
Mol Biochem Parasitol, 98 (1999), pp. 203-214
[23.]
S.M. Townson,P.F.L. Boreham,P. Upcroft,J.A. Upcroft
Resistance to the nitroheterocyclic drugs
Acta Trop, 56 (1994), pp. 173-194
[24.]
S.M. Townson,J.A. Upcroft,P. Upcroft
Characterisation and purification of pyruvate: ferredoxin oxidoreductase from Giardia duodenalis
Mol Biochem Parasitol, 79 (1996), pp. 183-193
[25.]
Boreham PFL, Smith NC, Shepherd RW. Drug resistance and the treatment of giardiasis. En: Wallis PM, Hammond BR (ed.). Advances in Giardia research. University of Calgary Press, Calgary, Alberta, Canadá.
[26.]
J.A. Upcroft,P. Upcroft
Drug resistance and Giardia
Parasitol Today, 4 (1993), pp. 187-190
[27.]
M. Müller
Mode of action of metronidazole an anaerobic bacteria and protozoa
Surgery, 993 (1983), pp. 165-171
[28.]
M.O. Robbie,R.L. Sweet
Metronidazole use in obstetrics and gynecology: A review
Am J Obstet Gynecol, 145 (1983), pp. 865-881
[29.]
D.G. Lindmark,M. Müller,H. Shio
Hydrogenosomes in Trichomonas vaginalis
J Parasitol, 61 (1975), pp. 552-554
[30.]
M. Müller
The hydrogenosome
J Gen Microbiol, 139 (1993), pp. 2.879-2.889 http://dx.doi.org/10.1099/00221287-139-12-3185
[31.]
E.M. Narcisi,W.E. Sector
In vitro effect of tinidazole and furazolidone on metronidazole- resistant Trichomonas vaginalis
Antimicrob Agents Chemother, 40 (1996), pp. 1.121-1.125
[32.]
M. Müller
Reductive activation of nitroimidazole in anaerobic microorganisms
Biochemical Pharm, 35 (1986), pp. 37-41
[33.]
W.H.R. Lumsdem,D.H.H. Robertson,R. Heyworth,C. Harrison
Treatment failure in Trichomonas vaginalis vaginitis
Genitourin Med, 64 (1988), pp. 217-218
[34.]
J.A. McFadzean,I.M. Pugh,S.L. Squires,J.P.F. Whelan
Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole
Br J Vener Dis, 45 (1969), pp. 161-162
[35.]
D.I. Edwards,E.J. Thompson,J. Tomusagne,D. Shanson
Inactivation of metronidazole by aerobic organisms
J Antimicrob Chemother, 5 (1979), pp. 315-316
[36.]
F. Wilmott,J. Say,D. Downey,A. Hookam
Zinc and recalcitrant trichomoniasis
Lancet, i (1983), pp. 1.053
[37.]
A. Barbeau,J. Donaldson
Zinc, taurine and epilepsy
Arch Neurol, 30 (1974), pp. 52-58
[38.]
G.D. Schott,H.T. Delues
Plasma zinc levels with anticonvulsant therapy
Br J Clin Pharmacol, 5 (1978), pp. 279-280
[39.]
S.C. Robinson
Trichomonal vaginitis resistant to metronidazole
Can Med Assoc J, 86 (1962), pp. 665
[40.]
J.G. Meingassner,J. Thurner
Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles
Antimicrob Agents Chemother, 15 (1979), pp. 254-257
[41.]
M. Müller,J.G. Meingassner,W.A. Miller,W.J. Ledger
Three metronidazoleresistant strains of Trichomonas vaginalis from the United States
Am J Obstet Gynecol, 138 (1980), pp. 808-812
[42.]
J. Kulda,M. Vojtěchowská,J. Tachezy,P. Demed,E. Kunzová
Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis
Br J Vener Dis, 58 (1982), pp. 394-399
[43.]
M.S. Sprott,A.M. Kearms,R.S. Pattman
Trichomonal vaginitis refractory to treatment: Case report
Genitourin Med, 64 (1988), pp. 369-372
[44.]
D.I. Edwards
Nitroimidazole drugs- action and resistance mechanisms. II. Mechanisms of resistance
J Antimicrob Chemother, 31 (1993), pp. 201-210
[45.]
K.A. Borchardt,Z. Li,M.Z. Zhang,H. Shing
An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test
Genitourin Med, 72 (1996), pp. 132-135
[46.]
B. Korner,H.K. Jensen
Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifurantel in vitro
Br J Vener Dis, 52 (1976), pp. 404-408
[47.]
J.G. Meingassner,L. Havelec,H. Mieth
Studies on strain sensitivity of Trichomonas vaginalis to metronidazole
Br J Vener Dis, 54 (1978), pp. 72-76
[48.]
J.G. Lossick,M. Müller,T.E. Gorrell
In vitro drug susceptibility and dose of metronidazole required for cure in cases of refractory vaginal trichomoniasis
J Infect Dis, 153 (1986), pp. 948-955
[49.]
T. Meri,T.S. Jokiranta,L. Suhonen,S. Meri
Resistance of Trichomonas vaginalis to metronidazole: Report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations
J Clin Microbiol, 38 (2000), pp. 763-767
[50.]
M. Müller,J.G. Lossick,T.E. Gorrell
In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal tricomoniasis
Sex Transm Dis, 15 (1988), pp. 17-24
[51.]
J. Tachezy,J. Kulda,E. Tomkova
Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro
Parasitol, 106 (1993), pp. 31-37
[52.]
R. Heyworth,D. Simpson,G.J.C. McNeillage,D.H.H. Robertson,H. Young
Isolation of Trichomonas vaginalis resistant to metronidazole
Lancet, 2 (1980), pp. 476-478
[53.]
A. Cerkasovová,J. Cerkasov,J. Kulda
Resistance of trichomonads to metronidazole
Acta Univ Carolinae- Biol, 30 (1988), pp. 485-503
[54.]
J. Kulda
Trichomonads, hidrogenosomes and drug resistance
Int J Parasitol, 29 (1999), pp. 199-212
[55.]
M. French,S. Krajden,J.G. Lossick,E. Wilk,J. Yang,J.S. Keystone,K. Elliot
Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain
CAMJ, 134 (1986), pp. 1.373-1.374
[56.]
N. Yarlett,N.C. Yarlett,D. Lloyd
Ferrodoxin- dependent reduction of nitroimidazole derivates in drug resistant and susceptible strains of Trichomonas vaginalis
Biochem Pharmacol, 35 (1985), pp. 1.703-1.708
[57.]
D. Quon,C. d’Oliveira,P. Johnson
Reduced transcription of the ferredoxin gene in metronidazole resistant Trichomonas vaginalis
Proc Natl Acad Sci USA, 89 (1992), pp. 4.402-4.406
[58.]
S.D. Sears,J. O’Hare
In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents
Antimicrob Agents Chemother, 32 (1988), pp. 1044-1146
[59.]
C.T. King,R.W. Finley,W.B. Lushbaugh
Quinolones lack efficacy for treatment of trichomoniasis
J Infect Dis, 164 (1991), pp. 624-625
[60.]
L. Gershenfeld
Povidone-iodine (PVP-I) as a trichomonicide
Am J Pharm, 334 (1962), pp. 324-331
[61.]
T. Lövgren,I. Salmela
In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents
Acta Pathol Microbiol Scand Sect B, 86 (1978), pp. 155-158
[62.]
C.H. Livengood,J.G. Lossick
Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9
Obstet Gynecol, 78 (1991), pp. 954-956
[63.]
J.A. Escario,A.M. Igea,M. Contreras,A.R. Martínez-Fernández,R. Claramunt,C. López
Antiparasitic activity of nine pyrazole derivatives against Trichomonas vaginalis, Entamoeba invadiens, and Plasmodium berghei
Ann Trop Med Parasitol, 82 (1988), pp. 257-262
[64.]
A. Herrero,C. Ochoa,J. Atienza,J.A. Escario,A. Gómez-Barrio,A.R. Martínez Fernández
Synthesis and antiprotozoal properties of 1,2,6-thiadiazine 1,1-dioxide derivatives
Arch Pharm (Weinheim), 325 (1992), pp. 509-514
[65.]
S.K. Katiyar,T.D. Edlind
Enhanced antiparasitic activity of lipophilic tetracyclines: Role of uptake
Antimicrob Agents Chemother, 35 (1991), pp. 2.198-2.202
[66.]
Y. Kaneda,T. Tanaka,T. Saw
Effects of berberibe, a plant alkaloid, on the growth of anaerobic protozoo in axenic culture
Tokai J Exp Clin Med, 15 (1990), pp. 417-423
[67.]
Y. Kaneda,M. Torii,T. Tanakat,M. Aikawa
In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia, and Trichomonas vaginalis
Ann Trop Med Parasitol, 85 (1991), pp. 417-425
[68.]
J.D. Sobel,V. Nagappan,P. Nyiersjesy
Metronidazole-resistant vaginal trichomoniasis- an emerging problem
N Engl J Med, 341 (1999), pp. 292-293 http://dx.doi.org/10.1056/NEJM199907223410417
[69.]
M. Valent,M. Klobusicky,L. Mokova,M. Karvaj,A. Janoska
Study of Trichomonas vaginalis resistance to metronidazole SPOFA
Bratisl Lek Listy, 68 (1977), pp. 277-281
[70.]
B.A. Dijkmans,A.M. Polderman,A.P. Heintz,R. van Furth
A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole
Ned Tijdschr Geneeskd, 126 (1982), pp. 2.193-2.195
[71.]
T. Giannone
Study on increased resistance to metronidazole in Trichomonas vaginalis strains in Lombardy
Minerva Ginecol, 24 (1972), pp. 354-355
[72.]
P. Bergsjo
Reduced sensitivity of Trichomonas vaginalis to metronidazole
Tidsskr Nor Laegeforen, 99 (1979), pp. 336
[73.]
A. Kurnatowska
Metronidazole resistance of Trichomonas vaginalis Donne
Wiad Parazytol, 15 (1969), pp. 399-401
[74.]
L.M. Korik
Strains of Trichomonas vaginalis resistant to metronidazole. Vestn Dermatol Venerol 1971; 45: 77-80. 75. Waitkins SA, Thomas DJ. Isolation of Trichomonas vaginalis resistant to metronidazole
Lancet, 45 (1971), pp. 77-80
[75.]
S.A. Waitkins,D.J. Thomas
Isolation of Trichomonas vaginalis resistant to metronidazole
Lancet, 2 (1981), pp. 590
[76.]
A. Forsgren,L. Forssman
Metronidazol-resistant Trichomonas vaginalis
Br J Vener Dis, 55 (1979), pp. 351-353
[77.]
J. Thurner,J.G. Meingassner
Isolation of Trichomonas vaginalis resistant to metronidazole
Lancet, 2 (1978), pp. 738
[78.]
J.G. Lossick,H.L. Kent
Tricomoniasis: trends in diagnosis and management
Am J Obstet Gynecol, 165 (1991), pp. 1.217-1.222
[79.]
J.H. Grossman,R.P. Galask
Persistent vaginitis caused by metronidazoleresistant trichomonas
Obstet Gynecol, 76 (1990), pp. 521-522
[80.]
I.H. Ahmed-Jushuf,A.E. Murray,J. McKeown
Managing trichomonal vaginitis refractory to conventional treatment with metronidazole
Genitourin Med, 64 (1988), pp. 25-29
[81.]
T. Voolman,P. Boreham
Metronidazole resistant Trichomonas vaginalis in Brisbane (letter)
Med J Aus, 159 (1993), pp. 490
[82.]
K.A. Hamed,A.E. Studemeister
Successful response of metronidazole-resistan trichomonal vaginitis to tinidazole
Sex Transm Dis, 19 (1992), pp. 339-340
[83.]
M.P. Dombrowski,R.J. Sokol,W.J. Brown,R.A. Bronsteen
Intravenous therapy of metronidazole-resistant Trichomonas vaginalis
Obstet Gynecol, 69 (1987), pp. 524-525
[84.]
D.J. Keilock,C.P. O’Mahoney
Sexually acquired metronidazole- resistant trichomoniasis in a lesbian couple
Genitourin Med, 72 (1996), pp. 60-61
[85.]
P. Nyirjesy,J.D. Sobel,M.V. Weitz,D.J. Leaman,S.P. Gelone
Difficult-to-treat trichomoniasis: Results with paromomycin cream
Clin Infect Dis, 26 (1998), pp. 968-988
[86.]
P. Nyirjesy,M.V. Weitz,S.P. Gelone,T. Feket
Paramomycin for nitroimidazole- resistant trichomonosis
Lancet, 346 (1995), pp. 1.110
[87.]
D.D. Coelho
Metronidazole resistant trichomoniasis sucessfully treated with paromomycin
Genitourin Med, 73 (1997), pp. 397-398
[88.]
R.M. van der Weiden,W.I. van de,D.H. Bogchelman,A.M. Polderman
Treatment failure in trichomoniasis and persistence of the parasites after Lactobacillus inmunotherapy; two case reports
Eur J Obstet Gynecol Reprod Biol, 34 (1990), pp. 171-178
[89.]
E.I. Ikeh,C.S. Bello,J.A. Ajayi
In vitro susceptibility of Trichomonas vaginalis strains to metronidazole- a Nigerian experience
Genitourin Med, 69 (1993), pp. 241-242
[90.]
J.G. Lossick
Therapy of urogenital trichomoniasis
Trichomonads Parasitic in Humans, pp. 326-341
[91.]
British Co-operative Clinical Group. An investigation, by questionnaire, of cases of recalcitrant vaginal trichomoniasis seen in genitourinary medicine clinics in the United Kingdom
Int J STD AIDS, 3 (1992), pp. 24-27
[92.]
F.J.C. Roe
Metronidazole: review of uses and toxicity
J Antimicrob Chemother, 3 (1977), pp. 205-212
[93.]
CID. Metronidazole-resistant Trichomonas vaginalis
Clin Infect Dis, 29 (1999), http://dx.doi.org/10.1086/520427
[94.]
Pérez S, Fernández-Verdugo A, Pérez F, Vázquez F. Prevalence of 5-nitroimidazoles- resistant Trichomonas vaginalis in Oviedo (Spain). Sex Transm Dis 2001; 28 (en prensa).
[95.]
F. Sorvillo,P. Kerndt
Trichomonas vaginalis and amplification of HIV- 1 transmission
[96.]
P. Heine,J.A. McGregor
Trichomonas vaginalis: a reeemerging pathogen
Clin Obstet Gynecol, 36 (1993), pp. 137-144
[97.]
J.D. Sobel
Management of vaginosis: prevention and treatment
Drug Invest, 8 (1994), pp. 26-34
[98.]
G.W. Csonka
Trichomonal vaginitis treated with one dose of metronidazole
Br J Vener Dis, 47 (1971), pp. 456-458
[99.]
K.R. Woodcock
Treatment of trichomonal vaginitis with a single oral of metronidazole
Br J Vener Dis, 48 (1972), pp. 65-68
[100.]
R.S. Morton
Metronidazole in the single-dose treatment of trichomoniasis in mend and women
Br J Vener Dis, 48 (1972), pp. 525-527
[101.]
R.N. Thin,M.A.E. Symonds,R. Booker,S. Cook,F. Langlet
Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis
Br J Vener Dis, 55 (1979), pp. 354-356
[102.]
W.D. Hager,S.T. Brown,S.J. Krauss,G.S. Kleris,G.J. Perkins,M. Henderson
Metronidazole for vaginal trichomoniasis. Seven days vs. single dose regimen
JAMA, 244 (1980), pp. 1.219-1.220
[103.]
E.D. Ralph,R. Darwish,T.W. Austin,E.A. Smith,F.L.M. Pattison
Susceptibility of Trichomonas vaginalis strains to metronidazole: Response to treatment
Sex Transm Dis, 10 (1983), pp. 119-122
[104.]
P. O-Prasertsawat,T. Jetsawangsri
Split-dose metronidazole or singledose tinidazole for the treatment of vaginal trichomoniasis
Sex Transm Dis, 19 (1992), pp. 295-297
[105.]
M.R. Spence,T.S. Harwell,M.C. Davies,J.L. Smith
The minimum single oral metronidazole dose for treating trichomoniasis: A randomized, blinded study
Obstet & Gynecol, 89 (1997), pp. 699-703 http://dx.doi.org/10.1016/j.ejogrb.2015.03.004
[106.]
N. Kawamura
Metronidazole and tinidazole in a single large dose for treating urogenital infections with Trichomonas vaginalis in men
Br J Vener Dis, 54 (1978), pp. 81-83
[107.]
R.A. Underhill,J.E. Peck
Causes of therapeutic failure after treatment of trichomonal vaginitis with metronidazole: Comparison of single-dose treatment with a standar regimen
Br J Clin Pract, 28 (1974), pp. 134-136
[108.]
J.R. Dykers
Single-dose metronidazole for trichomonal vaginitis
N Engl J Med, 293 (1975), pp. 23-24 http://dx.doi.org/10.1056/NEJM197507032930106
[109.]
F.J. Fleuryvan,W.S. Bergen,R.L. Prentice,J.G. Russell,J.A. Singleton,J.V. Standard
Single dose of two grams of metronidazole for Trichomonas vaginalis infection
Am J Obstet Gynecol, 128 (1997), pp. 320-322
[110.]
B.H. Tidwell,W.B. Lushbaugh,M.D. Laughlin,J.D. Cleary,R.W. Finley
A double-blind placebo-controlled trial of single-dose intravaginal versus single-dose oral metronidazole in the treatment of trichomonal vaginitis
J Infect Dis, 170 (1994), pp. 242-246
[111.]
P. Rodin,G. Hass
Flagyl in the treatment of trichomoniasis
Br J Vener Dis, 36 (1960), pp. 147-149
[112.]
J.N. Krieger,J.F. Alderete
Trichomonas vaginalis and trichomoniasis
Sexually Transmitted Diseases (3th edition), pp. 587-604
[113.]
P. Durel,J. Couture,P. Collart,G. Girot
Flagyl metronidazole
Br J Vener Dis, 36 (1960), pp. 154-162
[114.]
R.D. Catterall
Trichomonal infections of the genital tract
Med Clin North Am, 56 (1972), pp. 1.203-1.209
[115.]
Centers for Disease Control and Prevention. 1993 sexuallly transmitted diseases treatment guidelines
MMWR, 42 (1993), pp. 70-72
[116.]
S.K. Panja
Treatment of trichomoniasis with metronidazole rectal suppositories
Br J Vener Dis, 58 (1982), pp. 257-258
[117.]
T.W. Austin,E.A. Smith,R. Darwish,E.D. Ralph,F.L.M. Pattison
Metronidazole in a single dose for the treatment of trichomoniasis: Failure of a 1-g single dose
Br J Vener Dis, 58 (1982), pp. 121-123
[118.]
D.E. Soper
Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease
Infect Dis Obstet Gynecol, 2 (1995), pp. 242-247 http://dx.doi.org/10.1155/S1064744995000111
[119.]
L. duBouchet,J.A. McGregor,M. Ismail,W.M. McCormack
A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis
Sex Transm Dis, 25 (1998), pp. 176-179
[120.]
A.J. Pereyra,J.D. Lansing
Urogenital trichomoniasis: treatment with metronidazole in 2002 incarcerated women
Obstet Gynecol, 24 (1964), pp. 499-508
[121.]
Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases
MMWR, 47 (1998), pp. 74-75
[122.]
A.R. Wisdom,E.M.C. Dunlop
Trichomoniasis: Study of the disease and its treatment: II. The disease and its treatment in men
Br J Vener Dis, 41 (1965), pp. 93-95
[123.]
A.S. Latif,P.R. Mason,E. Marowa
Urethral trichomoniasis in men
Sex Transm Dis, 14 (1987), pp. 9-11
[124.]
J.N. Krieger,M. Verdon,N. Siegel,K.K. Holmes
Natural history of urogenital trichomoniasis in men
J Urol, 149 (1993), pp. 1.455--1.458
[125.]
J.M. Aubert,H.J. Sesta
Treatment of vaginal trichomoniasis: Single, 2- gram dose of metronidazole as compared with a seven-day course
J Reprod Med, 27 (1982), pp. 743-745
[126.]
G. Gabriel,E. Robertson,R.N.T. Thin
Single dose treatment of trichomoniasis
J Int Med Res, 10 (1982), pp. 129-130
[127.]
V. Palacio López,F. Vázquez Valdés
Vaginitis por Trichomonas vaginalis
Programa Nacional para la actualización de las ETS y SIDA (Tomo I), pp. 366-382
[128.]
F.E. Cunningham,D.M. Kraus,L. Brubaker,J.H. Fischer
Pharmacokinetics of intravaginal metronidazole gel
J Clin Pharmacol, 34 (1994), pp. 1.060-1.065
[129.]
L. duBouchet,M.R. Spence,M.F. Rein,M.R. Danzing,M.W. McCormack
Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrichloride, and allantoin in the treatment of symptomatic trichomoniasis
Sex Transm Dis, 24 (1997), pp. 156-160
[130.]
M. Dan,J.D. Sobel
Trichomoniasis as seen in a chronic vaginitis clinic
Infect Dis Obstet Gynecol, 4 (1996), pp. 77-84 http://dx.doi.org/10.1155/S1064744996000178
[131.]
J.G. Lossick
Chemotherapy of nitroimidazole resistant vaginal trichomoniasis
Acta Univ Carol Biol, 30 (1986), pp. 533-545
[132.]
S.A. Foster,O.G. Ramírez,A.H. Rapaport
Metronidazole and trichomanal vaginitis
Am J Obstet Gynecol, 87 (1963), pp. 1.013-1.023
[133.]
W.F. Peterson,F.W. Hansen,J.E. Stauch,C.D. Ryder
Trichomonal vaginitis: Epidemiology and therapy
Am J Obstet Gynecol, 97 (1967), pp. 472-478
[134.]
F.J. Kazmier
A significant interaction between metronidazole and warfarin
Mayo Clin Proc, 51 (1976), pp. 782-784
[135.]
K.W. Garey,K.A. Rodvold
Disulfiram reactions and anti-infective agents
Infect Med, 16 (1999), pp. 741-744
[136.]
R. Sharma,J. Pickering,W.M. McCormack
Trichomoniasis in a postmenopausal woman cured after discontinuation of estrogen replacement therapy
Sex Transm Dis, 24 (1997), pp. 543-545
[137.]
M. Rustia,P. Shubik
Induction of lung tumors and maligmant lymphomas in mice by metronidazole
J Natl Cancer Inst, 48 (1972), pp. 721-729
[138.]
C.M. Beard,K.L. Noller,W.M. O’Fallon,L.T. Kurland,M.B. Dockerty
Lack of evidence for cancer due to use of metronidazole
N Engl J Med, 301 (1979), pp. 519-522 http://dx.doi.org/10.1056/NEJM197909063011003
[139.]
C.M. Beard,K.L. Noller,W.M. O’Fallon,L.T. Kurland,D.C. Dahlin
Cancer after exposure to metronidazole
Mayo Clin Proc, 63 (1988), pp. 147-153
[140.]
M.D. Pearlman,C. Yashar,S. Ernst,W. Solomon
An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse to metronidazole
Am J Obstet Gynecol, 174 (1996), pp. 934-936
[141.]
H.P. Legal
The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets
Postgrad Med, 50 (1974), pp. 81S-83S
[142.]
M.F. Rein,M. Müller
Trichomonas vaginalis and tricomoniasis
Sexually Transmitted Diseases (2nd ed.), pp. 481-492
[143.]
L. Heisterberg
Placental transfer of metronidazole in the first trimester pregnancy
J Perinat Med, 12 (1984), pp. 43-45
[144.]
B.J. Struthers
Metronidazole appears not to be a human teratogen: review of the literature
Infect Dis Obstet Gynecol, 5 (1997), pp. 326-335 http://dx.doi.org/10.1155/S1064744997000574
[145.]
G.G.G. Donders
Treatment of sexually transmitted bacterial diseases in pregnant women
Drugs, 59 (2000), pp. 477-485
[146.]
E.L. Cornell,L.J. Goodman,M.M. Mathies
The culture, incidence and treatment of Trichomonas vaginalis
Am J Obstet Gynecol, 22 (1931), pp. 360
[147.]
L. Farouk,A. Salihi,J.P. Curran
Neonatal Trichomonas vaginalis: Report of three cases and a review of the literature
Pediatrics, 53 (1974), pp. 196-200
[148.]
I.S. Danesh,J.M. Stephen,J. Gorbach
Neonatal Trichomonas vaginalis infection
J Emergency Med, 13 (1995),
[149.]
J.A. Waitz,E.L. Moss,M.J. Weinstein
Chemotherapeutic evaluation of clotrimazole (Baby b 5097, 1 (o-chloro-diphenylbenzyl) imidazole)
Appl Microbiol, 22 (1971), pp. 891-898
[150.]
J.D. Schnell
The incidence of vaginal candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimozale
Postgrad Med J, 50 (1974), pp. 79S-81S
[151.]
H. Lohmeyer
Treatment of candidiasis and trichomoniasis of the female genital tract
Postgrad Med J, 50 (1974), pp. 78S-79S
[152.]
G. Saurina,L. DeMeo,W.M. Mc Cormack
Cure of metronidazole- and Trinidazole- resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole
Clin Infect Dis, 26 (1998), pp. 1.238-1.239
[153.]
M. Dumont,B. Croizat,P. Douillet
Traitement des vaginites à trichomonas par la paromomycine
Gynécologie Pratique, 15 (1964), pp. 247-251
[1.]
H. Spitzbart
Ist Paramomycin zur Behandlung der Trichomonaden-Infecktion ver der Frau geeignet? II. Klinische Erfahrungen
Zentralbl Gynakol, 88 (1996), pp. 563-566
[1.]
J.N. Krieger,M.F. Rein
Zinc sensitivity of Trichomonas vaginalis. In vitro studies and clinical implications
J Infect Dis, 146 (1982), pp. 341-345
[156.]
B.J. Andrews,H. Mylwaganam,A. Yule
Sensitivity of Trichomonas vaginalis, Tritrichomonas foetus and Giardia intestinalis to bacitracin and its zinc salt in vitro
Trans R Soc Trop Med Hyg, 88 (1994), pp. 704-706
[1.]
E.T. Houang,Z. Ahmet,A.G. Lawrence
Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy
Sex Transm Dis, 24 (1997), pp. 116-119
[158.]
F. Willmont,J. Say,D. Downey,A. Hookham
Zinc and recalcitrant trichomoniasis
Lancet, 1 (1983), pp. 1.053
[159.]
J. Weihe,C. Metelmann,K. Borner,J. Meingassner,C.E. Orfanos
Metronidazole- resistant trichomoniasis and successful therapy following high dosage
Hautarzt, 39 (1988), pp. 237-239
[160.]
N.M. Antonelli,S.J. Diehl,J.W. Wright
Intravaginal nonoxynol-9 versus oral metronidazole in the treatment of trichomoniasis ACOG 47th Annual Clinical Meeting (May 15-19), Philadelphia (Pennsylvania) 1999
Obstet Gynecol, 4 (1999), pp. 58S-59S
[161.]
M.J. Farthing,P.M. Inge,R.M. Pearson
Effect of D-propanolol on growth and motility of flagellate protozoa
J Antimicrob Chemother, 20 (1987), pp. 519-522
[162.]
R. Pavic,L. Stojkovic
Vaccination with Solco Trichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women
Gynakol Rundsch, 23 (1983), pp. 27-38
[163.]
F. Bonilla-Musoles,J.M. Sánchez-Pens,A. Pellices,F. Guevara,W.J. Ziegler
A vaccine against vaginal trichomoniasis in humans. A temporary solution of the problem?
Rev Esp Obstet Ginecol, 43 (1983), pp. 777-789
[164.]
R. Milovanovic,R. Crcic,L. Stojkovic
Serological study with Solco-Trichovac, a vaccine against Trichomonas vaginalis infection in women
Gynakol Rundsch, 23 (1983), pp. 39-45
[165.]
J.F. Alderete
Does lactobacilli vaccines for trichomoniasis, Solco-Trichovac, induce antibody reactive with Trichomonas vaginalis?
Genitourin Med, 64 (1988), pp. 118-123
[166.]
A. Gombosová,P. Demes,M. Valent
Immunotherapeutic effect of the lactobacillus vaccine, Solco-Trichvac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis
Genitourin Med, 62 (1986), pp. 107-110
[167.]
C.A. Wong,D. Wilson,T.A. Chew
Povidone-iodine in the treatment of metronidazole- resistant Trichomonas vaginalis
Aust N Z J Obstet Gyneaecol, 30 (1990), pp. 169-171
[168.]
M.T. Brown
Trichomoniasis
Practitioner, 209 (1972), pp. 639-644
[169.]
L.C. Ford,H.A. Hammill,R.J. DeLange,D.A. Bruckner,F. Suzuki-Chavez,K.L. Mickus,T.B. Lebherz
Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones
Am J Obstet Gynecol, 156 (1987), pp. 1.119-1.121
[170.]
P. Cappuccinely,C. Lattes,I. Cagliani,A. Negro Ponzi
Features of intravaginal Trichomonas vaginalis infection in the mouse and the effect of oestrogen treatment and immunodepression
G Batteriol Virol Immunol, 67 (1974), pp. 31-40
[171.]
G. Maestrone,R. Semar
Experimetnal intravaginal infection with Trichomonas foetus in guinea pigs
Chemotherapy, 12 (1967), pp. 137-145
[172.]
T. Azuma
A study of the parasitizing condition of Trichomonas vaginalis with especial reference to the relationship between estrogen and the growth of Trichomonas vaginalis
J Jap Obstet Gynec Soc, 15 (1968), pp. 168-172
[173.]
I.F. Stein,E.J. Cope
Trichomonas vaginalis (Donné)
Am J Obstet Gynecol, 25 (1993), pp. 819-825
[174.]
M.G. Martinitti,D. Savoia
Effect of some steroid homones on the growth of Trichomonas vaginalis
G Gatteriol Virol Immunol, 78 (1985), pp. 52-59
[175.]
F.L. Al-Salihi,J.P. Curran,J. Wang
Neonatal Trichomonas vaginalis: report of three cases and review of the literature
Pediatrics, 53 (1974), pp. 196-200
[176.]
P.P. Walker,R.E. Hall,J.D. Wilson
Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis
Int J STD & AIDS, 8 (1997), pp. 437
[177.]
P.G. Watson,R.S. Pattman
Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis
Int J STD & AIDS, 7 (1996), pp. 296-297
[178.]
R.S. Pattman,M.S. Sprott,A.M. Kearns,M. Earnshaw
Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports
Genitourin Med, 65 (1989), pp. 274-275
[179.]
W. Lotcki,K. Kuczynska,A. Malarewicz
Nitrofurantoin in the treatment of vaginal trichomoniasis in women
Wiad Parazytol, 15 (1969), pp. 385-386
[180.]
J.S. Ryu,J.W. Park,D.Y. Min
Effect of sodium nitrite on Trichomonas vaginalis
Korean J Parasitol, 33 (1995), pp. 349-356
[181.]
R. Romero Cabello,L. Robert Guerrero,M.R. Muñoz García,A. Geyne Cruz
Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico
Trans R Soc Trop Med Hyg, 91 (1997), pp. 701-703
[182.]
J.F. Rossignol,H. Maisonneuve
Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana
Am J Trop Med Hyg, 33 (1984), pp. 511-512
[183.]
O. Duombo,J.F. Rossignol,H. Pichard,H. Traore,M. Dembele,M. Diakite,F. Traore,D.A. Diallo
Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa
Am J Trop Med Hig, 56 (1997), pp. 637-639
[184.]
J.F. Rossignol,H. Hidalgo,M. Feregrino,F. Higuera,W.H. Gomez,J.L. Romero,J. Padierna,A. Gayne,M.S. Ayers
A double-blind placebo controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients
Transc R Soc Trop Med Hyg, 92 (1998), pp. 663-666
[185.]
A. Bicart-Seé,P. Massip,M.D. Linas,A. Datry
Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS
Antimicrob Agents Chemother, 44 (2000), pp. 167-168
[186.]
P.B. Mead,D.A. Eschenbanch,J.D. Sobel
Update on managemente of vaginitis
Contemporary OB/GYN, 44 (1999), pp. 26-47
[187.]
A.M. Gülmezoglu,F. Forna
Interventions for treating trichomoniasis in women. (Cochrane Review)
The Cochrane Library, issue 1,
[188.]
F. Gorlero,P. Bosco,M. Barbieri,C. Bertulessi,L. Pulici,L. Polvani,L. De Cecco
Fenticonazole ovules in the treatment of vaginal trichomonas infections. A double-blind randomized pilot clinical trail
Curr Ther Res, 51 (1992), pp. 367-376
[189.]
F. Gorlero,S. Macchiavello,L. Pellegatta,M.L. Airoldi,B. Gaffuri,L. Pulici,L. De Cecco
Evaluation of the efficacy and torelability of two different dosages of fenticonazole vaginal ovules (600 mg and 1.000 mg) in patients with vaginal trichomoniasis: A controlled, double- blind, randomized clinical trial versus placebo
Curr Ther Res, 55 (1994), pp. 510-518
[190.]
T.H. Leran,D. Vengadasalam
Treatment of trichomoniasis with a new anti-protozal compund (ocholoromethy-2-methyl-5-nitro-l-ethanol)
Br J Vener Dis, 49 (1973), pp. 69-71
[191.]
J.K.G. Mati,R.J. Wallace
The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth
East Afr Med J, 51 (1974), pp. 883-888
[192.]
P.H. Rees,H.E. McGlashan,V. Mwega
Single-dose treatment of vaginal trichomoniasis with tinidazole
East Afr Med J, 51 (1974), pp. 782-785
[193.]
V.E. Aimakhu
Vaginal trichomoniasis: One stat dose of tinidazole compared with a seven-day course of metronidazole
West Afr Med J, 23 (1975), pp. 97-100
[194.]
B. Nygaard,H. Kjaersgaard,B. Komer,R. Hammer Jensen
Single-dose treatment wit ornidazole (Tiberal (R)) and seven-day treatment with metronidazole (Flagyl (R)) in vaginal trichomoniasis
Ugeskr Laeg, 139 (1977), pp. 524-526
[195.]
J. Lyng,J. Christensen
A double-blind study of the value of treatment with a single dose tinidazole of partners to female with trichomoniasis
Acta Obstet Gynecol Scand, 50 (1981), pp. 199-201
[196.]
R. Anjaneylu,S.A. Gupte,D.B. Desai
Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole
J Int Med Res, 5 (1977), pp. 438-441
[197.]
G. Gabriel,E. Robertson,R.N. Thin
Single dose treatment of trichomoniasis
I. Int Med Res, 10 (1982), pp. 129-130
[198.]
M. Garud,M. Lulla,U. Saraiya,S. Vaidya
Oral single dose therapy of trichomonal vaginitis: comparison of tinidazole and metronidazole
J Obstet Gynaecol India, 28 (1978), pp. 347-350
[199.]
H.T.M. Rao,D.R. Shenoy
Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole
J Int Med Res, 6 (1978), pp. 46-49
[200.]
R. Sandvei,K. Hernborg
Behandling av trichomonas vaginalis
Tidsskr Nor Loegeforen, 99 (1979), pp. 316-317
[201.]
P. Chaisilwattana,P. Bhiraleus,P. Patanaprnich,C. Bhadrakow
Double blind comparative study of tinidazole and omidazole as a single dose treatment of vaginal trichomoniasis
J. Med Assoc Thailand, 63 (1980), pp. 448-452
[202.]
J. Serup,R.H. Jensen
Treatment of trichomoniasis vaginalis with single oral dose of ornidazole (Tiberal and tinidazole (Fasigyn). A controlled investigation
Ugeskr Laeg, 140 (1978), pp. 1.483-1.484
[203.]
C.N. Chunge,S. Kangethe,H.O. Pamba,J. Owate
Treatment of symptomatic trichomoniasis among adult women using oral nitroimidazoles
East Afr Med J, 69 (1992), pp. 398-401
[204.]
F. Sesti,E. Valli,C. Troisi,F. Ciancio,E. Piccione
Studio clinico comparativo sull’efficacia terapeutica di tinidazole vs. Ornidazole nel ttrattamento della trichomoniasi vaginale [comparative clinical study of the therapeutic efficacy of tinidazole and ornidazole in the treatment of vaginal trichomoniasis]
Giorn It Ost Gin, 12 (1990), pp. 83-84
Copyright © 2001. Elsevier España, S.L.
es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos